Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of amyl ethyl quin ether hydrochloride

A technology of penehyclidine hydrochloride and medicine, applied in the directions of medicine combination, medicine formula, resistance to vector-borne diseases, etc., can solve problems such as medical clinical effects that have been discovered and confirmed before, and no medical clinical effect has been discovered, and can reduce rigidity. and tremor symptoms, inhibition of salivation and excessive sweating, and obvious curative effect

Inactive Publication Date: 2005-09-21
JINZHOU AHON PHARM CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Prior to this, penehyclidine hydrochloride has been found and confirmed to have the efficacy and clinical efficacy of rescuing organophosphate poisoning, but no other medical clinical effects have been found

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] The application of the present invention in the preparation of medicaments for treating gastrointestinal diseases includes: A, the therapeutic application of peptic ulcer; Therapeutic application of hypermotility of the small intestine, dysentery and rectal irritation; C, inhibition of saliva secretion, salivation of Parkinson's disease, and saliva dysphagia caused by esophageal mechanical obstruction.

[0035] Medication can be taken orally, intramuscularly or intravenously, and the preferred dosage range is 0.01-10mg / time.

Embodiment 2

[0037] The application of the present invention in ophthalmic diseases in clinical medicine includes: A, pupil dilation, fundus examination, and iritis, keratitis, and anti-adhesion treatment applications; B, application for regulating paralysis in optometry.

[0038] The dosage form can be selected as eye drops or eye paint, and the preferred concentration is 0.03-3%.

Embodiment 3

[0040] The clinical application of the present invention in respiratory diseases includes: A, the application of relieving cold and acute and chronic rhinitis; B, the application of relieving asthma.

[0041] The dosage forms can be nasal drops or sprays, and the preferred concentration is 0.025-2.8.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A new application of pentaethylquinether hydrochloride in treating gastroenteropathy, ophthalmopathy, disease in respiratory tract, disease in central nerve system, etc is disclosed, which features high curative effect.

Description

Technical field: [0001] The invention relates to the application of penehyclidine hydrochloride, in particular to the application of penehyclidine hydrochloride in clinical medicine for gastrointestinal diseases, eye diseases, respiratory diseases, central nervous system diseases, anesthesia, urogenital tract renal colic and bladder irritation Syndrome, anti-septic shock, anti-biliary colic, etc. Background technique: [0002] Penehyclidine hydrochloride, English name: Penehyclidine Hydrochloride, its chemical name is 3-(2-cyclopentyl-2-hydroxy-2-phenylethoxy)quinuclidine hydrochloride, molecular formula: C 20 h 29 NO 2 • CH1, molecular weight: 351.92. Prior to this, penehyclidine hydrochloride has been found and confirmed to have the efficacy and clinical efficacy of rescuing organophosphate poisoning, but no other medical clinical effects have been found. Invention content: [0003] The purpose of the present invention is to propose new indications of penehyclidine h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/4375A61K31/439A61P1/04A61P11/02A61P11/06A61P25/16A61P27/02
CPCY02A50/30
Inventor 倪友洪蒲春霞雍萍曹勇王卫国
Owner JINZHOU AHON PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com